Exclusive: Vaccine makers Pfizer and BioNTech halted recruitment for a large US trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too low to generate the needed data www.reuters.com/business/healthcare-pharma...